Concurrently, obesity-associated insulin resistance inhibits the mTOR signaling pathway, diminishes muscle anabolic capacity, and drives ectopic lipid deposition within muscle tissue, forming intramuscular lipids (IMCLs) (31, 32). The gene discussed is MTOR; the disease is Insulin resistance.